Zobrazeno 1 - 8
of 8
pro vyhledávání: '"O Petter Veiby"'
Autor:
Melissa Gallery, Julie Zhang, Daniel P Bradley, Pamela Brauer, Donna Cvet, Jose Estevam, Hadi Danaee, Edward Greenfield, Ping Li, Mark Manfredi, Huay-Keng Loke, Claudia Rabino, Brad Stringer, Mark Williamson, Tim Wyant, Johnny Yang, Qing Zhu, Adnan Abu-Yousif, O Petter Veiby
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191046 (2018)
Guanylyl cyclase C (GCC) is a cell-surface protein that is expressed by normal intestinal epithelial cells, more than 95% of metastatic colorectal cancers (mCRC), and the majority of gastric and pancreatic cancers. Due to strict apical localization,
Externí odkaz:
https://doaj.org/article/a7f83c04c46d4ef7a8377d00d5a34370
Autor:
O. Petter Veiby, Jennifer Fretland, Mark G. Qian, Jayaprakasam Bolleddula, Robbie Robertson, Maria Borland, Melissa Saylor Landen, Cindy Q. Xia, Andy Zhu, Secil Koseoglu, Kurt Eng, Afrand Kamali, Bradley Stringer, Thomas A. Keating, Katharine C. Lai, Michael D. Smith, Michelle L. Ganno, Bret M. Bannerman, Melissa Gallery, Donna Cvet, Adnan O. Abu-Yousif
Guanylyl cyclase C (GCC) is a unique therapeutic target with expression restricted to the apical side of epithelial cell tight junctions thought to be only accessible by intravenously administered agents on malignant tissues where GCC expression is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7d56b0bf0e605a39ee70fc897c8b59
https://doi.org/10.1158/1535-7163.c.6542328.v1
https://doi.org/10.1158/1535-7163.c.6542328.v1
Autor:
O. Petter Veiby, Jennifer Fretland, Mark G. Qian, Jayaprakasam Bolleddula, Robbie Robertson, Maria Borland, Melissa Saylor Landen, Cindy Q. Xia, Andy Zhu, Secil Koseoglu, Kurt Eng, Afrand Kamali, Bradley Stringer, Thomas A. Keating, Katharine C. Lai, Michael D. Smith, Michelle L. Ganno, Bret M. Bannerman, Melissa Gallery, Donna Cvet, Adnan O. Abu-Yousif
Supplemental Figure 1: heavy and light chain sequences for 5F9, the human IgG1 monoclonal antibody (mAb) targeting the extracellular domain of GCC as described previously Supplemental Figure 2: Characterization of TAK-164 and chKTI-DGN549 by A) SDS P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc671e1a3ed72f6591ec22f46838181
https://doi.org/10.1158/1535-7163.22519161.v1
https://doi.org/10.1158/1535-7163.22519161.v1
Autor:
Bradley Stringer, Kurt Eng, Katharine C. Lai, Mark G. Qian, Jennifer Fretland, Melissa Gallery, Robbie Robertson, Melissa Saylor Landen, Cindy Q. Xia, Adnan O. Abu-Yousif, O. Petter Veiby, Afrand Kamali, Maria Borland, Secil Koseoglu, Bret Bannerman, Andy Z. X. Zhu, Michelle L. Ganno, Thomas A. Keating, Michael D. Smith, Donna Cvet, Jayaprakasam Bolleddula
Publikováno v:
Molecular Cancer Therapeutics. 19:2079-2088
Guanylyl cyclase C (GCC) is a unique therapeutic target with expression restricted to the apical side of epithelial cell tight junctions thought to be only accessible by intravenously administered agents on malignant tissues where GCC expression is a
Autor:
Tim Wyant, Melissa Gallery, Daniel Bradley, Adnan O. Abu-Yousif, Mark Williamson, Jose Estevam, Qing Zhu, Ping Li, Johnny J. Yang, Mark Manfredi, Claudia Rabino, Huay-Keng Loke, Edward A. Greenfield, O. Petter Veiby, Julie Zhang, Brad Stringer, Hadi Danaee, Donna Cvet, Pamela Brauer
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191046 (2018)
PLoS ONE
PLoS ONE
Guanylyl cyclase C (GCC) is a cell-surface protein that is expressed by normal intestinal epithelial cells, more than 95% of metastatic colorectal cancers (mCRC), and the majority of gastric and pancreatic cancers. Due to strict apical localization,
Autor:
Adnan O. Abu-Yousif, Bradley Stringer, Mengkun Zhang, Erik Koenig, Brittany Bahamon, O. Petter Veiby, Cong Li, Bret Bannerman, Andy Z. X. Zhu, Huyuan Yang, Pooja Shah, Kazuho Nishimura
Publikováno v:
Cancer Research. 78:3916-3916
Guanylyl cyclase C (GCC) is a cell surface protein expressed in more than 95% of metastatic colorectal cancers and in the majority of gastric and pancreatic cancers, making GCC an attractive antibody-drug conjugate (ADC) target. TAK-164 is an ADC com
Autor:
Cindy Q. Xia, Afrand Kamali, Mark G. Qian, Bradley Stringer, Thomas A. Keating, Kurt Eng, Michelle L. Ganno, Michael D. Smith, Secil Koseoglu, Bret Bannerman, O. Petter Veiby, Jayaprakasam Bolleddula, Katharine C. Lai, Donna Cvet, Melissa Gallery, Adnan O. Abu-Yousif
Publikováno v:
Molecular Cancer Therapeutics. 17:B120-B120
TAK-164 is an antibody-drug conjugate comprising a full-length, fully human IgG1 monoclonal antibody (mAb) directed towards the extracellular domain of guanylyl cyclase C (GCC). The mAb is conjugated using the peptide-linked indolino-benzodiazepine D
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.